Veeva Commercial Summit to Feature Biopharma's AI Successes and the Path to Agentic Commercial
argenx, Bayer, Boehringer Ingelheim, Genentech, Gilead, GSK, Merck, Novo Nordisk, Takeda, and Vertex share how they are redefining engagement across sales, marketing, and medical
Veeva will highlight its vision for Agentic Commercial, bringing together industry-specific AI, data, and applications to help the industry advance and deliver better medicine to more patients. Organizations ranging from top 20 biopharmas to emerging biotechs will share how they are leveraging new strategies, technologies, and insights to improve engagement and deliver measurable value.
More than 100 sessions at Summit will highlight what's new in Commercial Cloud and Data Cloud, and customer successes, including:
Accelerating Agentic Commercial at scale
- Genentech, Gilead, and Novo Nordisk advancing innovation with next-generation CRM
- GSK's vision for shaping customer engagement with Vault CRM and Veeva AI
- Avidity Biosciences, A Novartis Company, and Boehringer Ingelheim's agentic content strategy for faster quality reviews
- Boehringer Ingelheim and Gilead giving doctors and patients instant, compliant answers
Precision data powering AI, faster insights, actions, and launch success
- Merck and Takeda integrating deep data to drive business processes and AI
- MoonLake and Unicycive using modern data to quickly identify and engage patients
- argenx's media measurement framework for its DTC launch strategy
Medical driving impact and improved patient outcomes
- GSK and Vertex establishing a modern operating system for medical affairs
- Astellas, Bayer, and Chiesi USA capturing and sharing medical insights to drive action
With more than 2,000 industry professionals, Veeva Commercial Summit is the largest commercial and medical event in
About Veeva Systems
Veeva delivers the industry cloud for life sciences with software, AI, data, and consulting. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
Veeva Forward-Looking Statements
This release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-K for the fiscal year ended
Contact:
Veeva Systems
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/veeva-commercial-summit-to-feature-biopharmas-ai-successes-and-the-path-to-agentic-commercial-302771854.html
SOURCE Veeva Systems
